Last updated 2026-07-20
- Raised $10.3M Undisclosed Round led by Bill & Melinda Gates Foundation, Oct 2024
- Raised $7.3M Undisclosed Round led by Pontifax, Jul 2008
- Raised $12M Undisclosed Round led by Ziegler Meditech Equity Partners, Oct 2006
Total raised
$32.5M
Last: Undisclosed Round 2024-11
Stage
Mature
Founded
2024
Headcount
19
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Interna Therapeutics is a highly innovative Israeli bio-pharmaceutical company that develops a universal platform called Molecular Nano-Motors (MNMs) for delivering macromolecule drugs into cells using membrane electrical forces. The company is focused on infectious and non-infectious respiratory diseases and is also pursuing partnerships to license its technology to pharmaceutical companies. Interna Therapeutics was formed in November 2024 through the merger of Aposense Ltd. and its subsidiary SirVir.
Funding history · 5 rounds · $32.5M total
2024-10
Undisclosed Round
$10.3M
★ Bill & Melinda Gates Foundation
2010-05
Follow-on PO
Undisclosed
2010-04
Undisclosed Round
$3.0M
★ Pontifax★ Ziegler Meditech Equity Partners
2008-07
Undisclosed Round
$7.3M
★ Pontifax★ Federman & Sons★ Phoenix Insurance★ Polar Investments★ Technorov Holdings★ Bargal R&D Investment★ Docor International Management★ Ziegler Meditech Equity PartnersClal Biotechnology Industries (CBI)
2006-10
Undisclosed Round
$12.0M
★ Ziegler Meditech Equity Partners
Headcount over time
From 28 (2018-10) to 18 (2025-12) · -10 (-36%) · 26 points · source: Finder history + radar grounding
Q&A
- What is Interna Therapeutics' primary focus?
- Interna Therapeutics is an innovative biotechnology company focused on drug delivery via electrical nano motors, specifically developing Molecular Nano-Motors (MNMs) for macromolecule delivery.
- When was Interna Therapeutics founded?
- Interna Therapeutics was founded in October 1996.
- How many employees does Interna Therapeutics have?
- Interna Therapeutics has 11-50 employees.
- What is the total amount of funding Interna Therapeutics has raised to date?
- Interna Therapeutics has raised a total of $57,550,000 USD.
- When was Interna Therapeutics' most recent funding round, and who were the lead investors?
- Interna Therapeutics' most recent funding round occurred in November 2024, with the Bill & Melinda Gates Foundation as a lead investor.
- What is the status of Interna Therapeutics' COVID-19 drug development?
- A Phase I study for Interna Therapeutics' COVID-19 drug began in September 2024.
- What is Interna Therapeutics' core technology?
- Interna Therapeutics' core technology is Molecular Nano-Motors (MNMs), which leverage membrane electrical forces to facilitate the entry of charged molecules into cells for drug delivery.
- What types of diseases does Interna Therapeutics' technology aim to address?
- Interna Therapeutics' technology aims to provide new treatment options for a wide range of diseases by delivering difficult-to-deliver molecules such as oligonucleotide-based drugs (siRNA, ASO).
Team · 1
Jacob Gottenstein
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
BiologicalsMoleculesMaterials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
gastroenterologycns-disorderspulmonarycanceroncologyparkinsonpharmaceuticalsdrug-deliverygeneticsnanotechnologypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | interna.bio |
|---|---|
| linkedin.com/company/1833144 | |
| YouTube | youtube.com/user/Aposense |
Identifiers & details
| Former names | NST |
|---|---|
| Founded | 2024-11 |
| Employees (exact) | 19 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | interna.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512380296 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1996-10-09 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), shares_capital (1) |
| Registered address | אודם 5 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2025-09-07 | העברת מניות |